Santhera Pharmaceuticals
Signal active
Organization
Contact Information
Overview
Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases. This area of high unmet medical need includes many orphan and niche indications with no current therapy.
About
Industries
Biotechnology, Health Care, Pharmaceutical
Founded
2004
Employees
51-100
Headquarters locations
Switzerland, Europe
Social
N/A
Profile Resume
Santhera Pharmaceuticals headquartered in Switzerland, Europe, operates in the Biotechnology, Health Care, Pharmaceutical sector. The company focuses on Biotechnology and has secured $39.0B in funding across 144 round(s). With a team of 51-100 employees, Santhera Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Santhera Pharmaceuticals, raised $11.1M. Discover more about their projects, partnerships, and impact on our platform.
Employees
Funding Rounds
Funding rounds
12
Investors
1
Lead Investors
0
Total Funding Amount
$270.7M
Details
3
Santhera Pharmaceuticals has raised a total of $270.7M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2005 | Early Stage Venture | 19.0M | ||
| 2006 | Late Stage Venture | 19.0M | ||
| 2004 | Early Stage Venture | 18.6M |
Investors
Santhera Pharmaceuticals is funded by 36 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Santhera Pharmaceuticals | - | FUNDING ROUND - Santhera Pharmaceuticals | 18.6M |
| NGN Capital | - | FUNDING ROUND - NGN Capital | 18.6M |
| Santhera Pharmaceuticals | - | FUNDING ROUND - Santhera Pharmaceuticals | 18.6M |
| Heidelberg Innovation | - | FUNDING ROUND - Heidelberg Innovation | 18.6M |
Recent Activity
There is no recent news or activity for this profile.